These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 16223936)
1. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. Lehtopolku M; Hakanen AJ; Siitonen A; Huovinen P; Kotilainen P J Antimicrob Chemother; 2005 Dec; 56(6):1134-8. PubMed ID: 16223936 [TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. Hakanen AJ; Lehtopolku M; Siitonen A; Huovinen P; Kotilainen P J Antimicrob Chemother; 2003 Dec; 52(6):1035-9. PubMed ID: 14613954 [TBL] [Abstract][Full Text] [Related]
3. In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility. Kotilainen P; Pitkänen S; Siitonen A; Huovinen P; Hakanen AJ Ann Clin Microbiol Antimicrob; 2005 Sep; 4():12. PubMed ID: 16143044 [TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics]. García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460 [TBL] [Abstract][Full Text] [Related]
5. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni. Pasquali F; Lucchi A; Manfreda G Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250 [No Abstract] [Full Text] [Related]
6. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method]. Žemličková H; Jakubů V; Marejková M; Urbášková P Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. McDermott PF; Bodeis SM; English LL; White DG; Walker RD; Zhao S; Simjee S; Wagner DD J Infect Dis; 2002 Mar; 185(6):837-40. PubMed ID: 11920303 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae. Daporta MT; Muñoz Bellido JL; Guirao GY; Hernández MS; García-Rodríguez JA Int J Antimicrob Agents; 2004 Aug; 24(2):185-7. PubMed ID: 15288320 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus. Yamamoto N; Fujita J; Shinzato T; Higa F; Tateyama M; Tohyama M; Nakasone I; Yamane N Int J Antimicrob Agents; 2006 Feb; 27(2):171-3. PubMed ID: 16417990 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Wardak S; Szych J; Zasada AA; Gierczynski R Antimicrob Agents Chemother; 2007 Mar; 51(3):1123-5. PubMed ID: 17210776 [TBL] [Abstract][Full Text] [Related]